Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Stanford University School of Medicine: Stanford, CA, US

2018-10-01 to present | Assistant Professor (Pediatrics)
Employment
Source: Self-asserted source
Sneha Ramakrishna

Education and qualifications (5)

National Cancer Institute: Bethesda, Maryland, US

2015 to 2018 | Fellow (Pediatric Oncology Branch)
Qualification
Source: Self-asserted source
Sneha Ramakrishna

Johns Hopkins Hospital: Baltimore, Maryland, US

2015 to 2018 | Fellow (Pediatric Hematology-Oncology)
Education
Source: Self-asserted source
Sneha Ramakrishna

The Children's Hospital of Philadelphia: Philadelphia, PA, US

2012 to 2015 | Pediatric Resident
Education
Source: Self-asserted source
Sneha Ramakrishna

Cleveland Clinic Lerner College of Medicine: Cleveland, OH, US

2007 to 2012
Qualification
Source: Self-asserted source
Sneha Ramakrishna

University of Chicago: Chicago, IL, US

2003 to 2007
Qualification
Source: Self-asserted source
Sneha Ramakrishna

Works (36)

Allogeneic approach unlocks CAR T cell benefits in solid tumors

Nature Medicine
2025-02-07 | Journal article
DOI: 10.1038/s41591-025-03510-3
Contributors: Rozalyn Chok; Sneha Ramakrishna
Source: check_circle
Crossref

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study.

Lancet (London, England)
2024-07-09 | Journal article
DOI: 10.1016/S0140-6736(24)00746-3
PMID: 38996463
Part of ISSN: 1474-547X
Contributors: Matthew J Frank; John H Baird; Anne Marijn Kramer; Hrishikesh K Srinagesh; Shabnum Patel; Annie Kathleen Brown; Jean S Oak; Sheren F Younes; Yasodha Natkunam; Mark P Hamilton et al.
Source: check_circle
Stanford University

CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.

Leukemia
2024-03-15 | Journal article
DOI: 10.1038/s41375-024-02220-y
PMC: 4993814
PMID: 38491306
Part of ISSN: 1476-5551
Contributors: Liora M Schultz; Nikeshan Jeyakumar; Anne Marijn Kramer; Bita Sahaf; Hrishi Srinagesh; Parveen Shiraz; Neha Agarwal; Mark Hamilton; Courtney Erickson; Ashley Jacobs et al.
Source: check_circle
Stanford University

Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy.

Frontiers in immunology
2024-01-01 | Journal article
DOI: 10.3389/fimmu.2024.1423487
PMID: 39386214
WOSUID:

MEDLINE:39386214

Part of ISSN: 1664-3224
Contributors: Johns, Claire; Erickson, Courtney; Jacobs, Ashley; Moon, Jennifer; Baggott, Christina; Dagher, Regina; Nadel, Helen; Balagtas, Jay; Aftandilian, Catherine; Ramakrishna, Sneha et al.
Source: check_circle
Stanford University

Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.

Cancer cell
2023-12-18 | Journal article
DOI: 10.1016/j.ccell.2023.11.011
PMID: 38134936
Contributors: Kaczanowska S; Murty T; Alimadadi A; Contreras CF; Duault C; Subrahmanyam PB; Reynolds W; Gutierrez NA; Baskar R; Wu CJ et al.
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

INSPIRED Symposium Part 4B: CAR T cell correlative studies-established findings and future priorities.

Transplantation and cellular therapy
2023-10-18 | Journal article
DOI: 10.1016/j.jtct.2023.10.012
PMID: 37863355
Part of ISSN: 2666-6367
Contributors: John A Ligon; Sneha Ramakrishna; Francesco Ceppi; Friso Gj Calkoen; Caroline Diorio; Kara L Davis; Elad Jacoby; Stephen Gottschalk; Liora M Schultz; Christian M Capitini
Source: check_circle
Stanford University

Tumor inflammation-associated neurotoxicity.

Nature medicine
2023-04-06 | Journal article
DOI: 10.1038/s41591-023-02276-w
PMC: 7238960
PMID: 37024595
Part of ISSN: 1546-170X
Contributors: Jasia Mahdi; Jorg Dietrich; Karin Straathof; Claire Roddie; Brian J Scott; Tom Belle Davidson; Laura M Prolo; Tracy T Batchelor; Cynthia J Campen; Kara L Davis et al.
Source: check_circle
Stanford University

Data from Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6527751
Contributors: Sneha Ramakrishna; Steven L. Highfill; Zachary Walsh; Sang M. Nguyen; Haiyan Lei; Jack F. Shern; Haiying Qin; Ira L. Kraft; Maryalice Stetler-Stevenson; Constance M. Yuan et al.
Source: check_circle
Crossref

Data from Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6527751.v1
Contributors: Sneha Ramakrishna; Steven L. Highfill; Zachary Walsh; Sang M. Nguyen; Haiyan Lei; Jack F. Shern; Haiying Qin; Ira L. Kraft; Maryalice Stetler-Stevenson; Constance M. Yuan et al.
Source: check_circle
Crossref

Supplementary Figures and Table from Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22470984
Contributors: Sneha Ramakrishna; Steven L. Highfill; Zachary Walsh; Sang M. Nguyen; Haiyan Lei; Jack F. Shern; Haiying Qin; Ira L. Kraft; Maryalice Stetler-Stevenson; Constance M. Yuan et al.
Source: check_circle
Crossref

Supplementary Figures and Table from Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22470984.v1
Contributors: Sneha Ramakrishna; Steven L. Highfill; Zachary Walsh; Sang M. Nguyen; Haiyan Lei; Jack F. Shern; Haiying Qin; Ira L. Kraft; Maryalice Stetler-Stevenson; Constance M. Yuan et al.
Source: check_circle
Crossref

Supplementary Methods from Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22470981
Contributors: Sneha Ramakrishna; Steven L. Highfill; Zachary Walsh; Sang M. Nguyen; Haiyan Lei; Jack F. Shern; Haiying Qin; Ira L. Kraft; Maryalice Stetler-Stevenson; Constance M. Yuan et al.
Source: check_circle
Crossref

Supplementary Methods from Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22470981.v1
Contributors: Sneha Ramakrishna; Steven L. Highfill; Zachary Walsh; Sang M. Nguyen; Haiyan Lei; Jack F. Shern; Haiying Qin; Ira L. Kraft; Maryalice Stetler-Stevenson; Constance M. Yuan et al.
Source: check_circle
Crossref

Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD

Journal for ImmunoTherapy of Cancer
2023-02 | Journal article
DOI: 10.1136/jitc-2022-004851
Contributors: Liora Schultz; Kara Lynn Davis; Ann Walkush; Christina Baggott; Courtney Erickson; Sneha Ramakrishna; Catherine Aftandilian; Norman Lacayo; Helen Ruth Nadel; Jean Oak et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

MAJOR TUMOR REGRESSIONS IN H3K27M-MUTATED DIFFUSE MIDLINE GLIOMA (DMG) FOLLOWING SEQUENTIAL INTRAVENOUS (IV) AND INTRACEREBROVENTRICULAR (ICV) DELIVERY OF GD2-CAR T-CELLS

2022-06-01 | Conference paper
WOSUID:

WOS:000840122400074

Part of ISSN: 1523-5866
Part of ISSN: 1522-8517
Contributors: Monje, Michelle; Majzner, Robbie; Mahdi, Jasia; Ramakrishna, Sneha; Patel, Shabnum; Chinnasamy, Harshini; Yeom, Kristen; Schultz, Liora; Barsan, Valentin; Richards, Rebecca et al.
Source: check_circle
Stanford University

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Nature
2022-02-07 | Journal article
DOI: 10.1038/s41586-022-04489-4
Part of ISSN: 0028-0836
Part of ISSN: 1476-4687
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

CD22-CAR T-Cell Therapy Mediates High Durable Remission Rates in Adults with Large B-Cell Lymphoma Who Have Relapsed after CD19-CAR T-Cell Therapy

2021-11-23 | Conference paper
DOI: 10.1182/blood-2021-152145
WOSUID:

WOS:000736398803041

Part of ISSN: 1528-0020
Part of ISSN: 0006-4971
Contributors: Frank, Matthew J.; Baird, John H.; Patel, Shabnum; Craig, Juliana; Spiegel, Jay Y.; Ehlinger, Zachary; Chinnasamy, Harshini; Younes, Sheren F.; Oak, Jean S.; Natkunam, Yasodha et al.
Source: check_circle
Stanford University

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.

Nature medicine
2021-07-26 | Journal article
DOI: 10.1038/s41591-021-01436-0
PMID: 34312556
WOSUID:

MEDLINE:34312556

Part of ISSN: 1546-170X
Part of ISSN: 1078-8956
Contributors: Spiegel, Jay Y.; Patel, Shabnum; Muffly, Lori; Hossain, Nasheed M.; Oak, Jean; Baird, John H.; Frank, Matthew J.; Shiraz, Parveen; Sahaf, Bita; Craig, Juliana et al.
Source: check_circle
Stanford University

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

Blood
2021-04-29 | Journal article
DOI: 10.1182/blood.2020009432
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

Use of cardiac radiation therapy as bridging therapy to CAR‐T for relapsed pediatric B‐cell acute lymphoblastic leukemia

Pediatric Blood & Cancer
2021-03 | Journal article
DOI: 10.1002/pbc.28870
Part of ISSN: 1545-5009
Part of ISSN: 1545-5017
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

Using single-cell analysis to predict CAR T cell outcomes

Nature Medicine
2020-12 | Journal article
DOI: 10.1038/s41591-020-01157-w
Part of ISSN: 1078-8956
Part of ISSN: 1546-170X
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

Use of Chimeric Antigen Receptor Modified T Cells With Extensive Leukemic Myocardial Involvement

JACC: CARDIOONCOLOGY
2020-11-01 | Journal article
DOI: 10.1016/j.jaccao.2020.08.009
WOSUID:

WOS:000613114700018

Part of ISSN: 2666-0873
Contributors: Han, Brian; Montiel-Esparza, Raul; Chubb, Henry; Kache, Saraswati; Schultz, Liora M.; Davis, Kara L.; Ramakrishna, Sneha; Su, Lillian
Source: check_circle
Stanford University

Delayed cancer diagnoses and high mortality in children during the COVID‐19 pandemic

Pediatric Blood & Cancer
2020-09 | Journal article
DOI: 10.1002/pbc.28427
Part of ISSN: 1545-5009
Part of ISSN: 1545-5017
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report

Journal for ImmunoTherapy of Cancer
2020-09 | Journal article
DOI: 10.1136/jitc-2020-001073
Part of ISSN: 2051-1426
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

Prospects and challenges for use of CAR T cell therapies in solid tumors

Expert Opinion on Biological Therapy
2020-05-03 | Journal article
DOI: 10.1080/14712598.2020.1738378
Part of ISSN: 1471-2598
Part of ISSN: 1744-7682
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia

Current Oncology Reports
2020-02 | Journal article
DOI: 10.1007/s11912-020-0875-2
Part of ISSN: 1523-3790
Part of ISSN: 1534-6269
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

Supercharging your CAR

Blood
2020-02-27 | Journal article
DOI: 10.1182/blood.2019004469
Contributors: Sneha Ramakrishna; Kara L. Davis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence

Clinical Cancer Research
2019-09-01 | Journal article
DOI: 10.1158/1078-0432.CCR-18-3784
Contributors: Sneha Ramakrishna; Steven L. Highfill; Zachary Walsh; Sang M. Nguyen; Haiyan Lei; Jack F. Shern; Haiying Qin; Ira L. Kraft; Maryalice Stetler-Stevenson; Constance M. Yuan et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22.

Molecular therapy oncolytics
2018-11-06 | Journal article
DOI: 10.1016/j.omto.2018.10.006
PMID: 30581986
PMC: PMC6300726
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.

Nature medicine
2017-11-20 | Journal article
DOI: 10.1038/nm.4441
PMID: 29155426
PMC: PMC5774642
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas.

Cancer immunology research
2016-08-22 | Journal article
DOI: 10.1158/2326-6066.CIR-15-0230
PMID: 27549124
PMC: PMC5050151
Source: Self-asserted source
Sneha Ramakrishna
grade
Preferred source (of 2)‎

Myocardium defects and ventricular hypoplasia in mice homozygous null for the Forkhead Box M1 transcription factor.

Developmental dynamics : an official publication of the American Association of Anatomists
2007-04-01 | Journal article
DOI: 10.1002/dvdy.21113
PMID: 17366632
Source: Self-asserted source
Sneha Ramakrishna

Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression.

Molecular and cellular biology
2007-01-29 | Journal article
DOI: 10.1128/MCB.01736-06
PMID: 17261592
PMC: PMC1899898
Source: Self-asserted source
Sneha Ramakrishna

The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.

Cancer research
2006-02-01 | Journal article
DOI: 10.1158/0008-5472.can-05-3003
PMID: 16489016
Source: Self-asserted source
Sneha Ramakrishna

Functional characterization of evolutionarily conserved DNA regions in forkhead box f1 gene locus.

The Journal of biological chemistry
2005-09-06 | Journal article
DOI: 10.1074/jbc.m506531200
PMID: 16144835
Source: Self-asserted source
Sneha Ramakrishna

The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature.

The Journal of biological chemistry
2005-04-06 | Journal article
DOI: 10.1074/jbc.m500936200
PMID: 15817462
Source: Self-asserted source
Sneha Ramakrishna

Peer review (5 reviews for 2 publications/grants)

Review activity for Journal for immunotherapy of cancer. (3)
Review activity for Nature medicine. (2)
How many people are using ORCID?